CoreValve Asks High Court To Define Patent Enablement

Law360, Washington (May 7, 2013, 7:42 PM EDT) -- CoreValve Inc. urged the U.S. Supreme Court on Monday to clarify the Federal Circuit's prior art enablement doctrine, alleging the court adopted three battling standards and erroneously upheld Edward Lifesciences Corp.'s $73.9 million infringement award over catheter heart valve technology.

In November, the Federal Circuit upheld Edwards' jury award and affirmed the company's patent-in-suit was both valid and infringed, but instructed a judge to review his denial of an Edwards' post-trial request for an injunction blocking CoreValve from making infringing devices used to treat patients with...
To view the full article, register now.